Dr Marta Erlandson – Improving the Outlook for Children with Congenital Heart Disease

Jan 5, 2022 | Biology, Health and Medicine

Congenital heart disease (CHD) is one of the most common birth defects across the globe. Although prospects and survival rates are improving, there is scant understanding or help available to get children with CHD active. Many believe physical activity is risky or outright dangerous, and as a result, children with CHD are at risk of obesity and other chronic conditions later in life. Dr Marta Erlandson from the University of Saskatchewan has aided the creation of CHAMPS, an innovative program for children with CHD, where researchers and children are learning how to manage the disorder from each other.

Congenital Heart Disease

Congenital heart disease (CHD) is a term used to describe a range of birth defects that impact the normal function of the heart. It is one of the most common types of birth defect and is often diagnosed through an ultrasound scan before a baby is born. Although there is no clear-cut reason for the development of CHD, Down’s syndrome and other alterations to the chromosomes (genetic make-up) are often risk factors. The behaviours of an expectant mother can also increase the risk of CHD. These may include smoking and drinking, having poorly uncontrolled type 1 or type 2 diabetes and taking certain medications such as statins during pregnancy.

The various types of CHD can be found both alone and in combination with others. Examples include having a hole in the heart between the two chambers, which is known as a septal defect, and having an abnormally narrow pulmonary valve which usually controls the flow of blood from the heart to the lungs, which is known as pulmonary valve stenosis. These structural defects can cause various symptoms in babies and children such as a rapid heartbeat and breathing problems especially when feeding, severe fatigue, swelling in the abdomen, legs or eyes, and a blue tinge to the skin called cyanosis. These issues are usually obvious when a baby is still very young, but if the heart defects are mild, the child might not show related problems until they are older.

Mild defects do not always create major problems and can even improve without intervention. However, many children with CHD require surgery (or even multiple surgeries) to restore more normal structure and function to the heart. Thanks to advances in medicine and surgery, this is often successfully achieved, but those living with CHD tend to require monitoring and treatment throughout their life due to the potential for developing future issues. CHD increases the risk for associated health complications such as blood clots, heart valve and rhythm issues and endocarditis, which is an infection of the heart and valve lining.

Credit: Marta Erlandson.

Improving the Outlook for Congenital Heart Disease

The detection and treatment of CHD have greatly improved over the years, so much so that within the next decade, 1 out of every 150 young adults is expected to be living with the disorder. Although these promising survival rates provide the hope of a long life for children living with CHD, facing the possible complications can prove challenging.

Critically, many children with CHD are significantly less active than their peers, resulting in lower aerobic fitness and higher risk of early-onset cardiovascular diseases. Understanding and living with such a serious disorder can also cause mental health issues in children as such, both short- and long-term anxiety.

Investigating how these issues can be improved is Dr Marta Erlandson at the University of Saskatchewan in Canada. In the College of Kinesiology, Dr Erlandson and her colleagues are working to better understand how the needs of children with CHD can be met. According to Dr Erlandson, ‘comprehensive chronic disease management (CDM) specific to the physical activity and mental health needs for children with CHD is currently lacking and requires resolution to prevent future health problems associated with CHD and physical inactivity.’ There is a growing body of evidence that CHD disproportionately increases morbidity, mortality, and health care costs in adulthood.

Therefore, researching and recognising how children with CHD can be aided in the development of healthy lifestyle behaviours earlier rather than later is an essential step in improving their lives. ‘We aim to understand the physical and psychological health of children with CHD and create a sustainable comprehensive chronic disease management program for these children,’ explains Dr Erlandson.

‘We aim to understand the physical and psychological health of children with CHD and create a sustainable comprehensive chronic disease management program for these children.’

Children undertaking swimming as part of CHAMPS. Credit: Marta Erlandson.

The Children’s Healthy-Heart Activity Monitoring Program of Saskatchewan

To carry out this CHD research, Dr Erlandson and her team created the Children’s Healthy-Heart Activity Monitoring Program of Saskatchewan, also known as CHAMPS. This program includes an annual week-long summer camp style CDM for children with CHD all across Saskatchewan – the only one of its kind in Canada. Initiated in 2014 and funded by the Jim Pattison Children’s Hospital Foundation and other supporters, the camp now welcomes around thirty 7–15 year-olds each year.

CHAMPS gives these young people the opportunity to experience a supportive and safe summer camp that aims to build their confidence and encourage them to be physically active. Most of them have a large surgical scar on their chest about which they may felt self-conscious and perhaps did not realise others shared. But through the chance to have conversations about their experiences and activities like swimming, the children are able to connect with others like them and come to see they are not alone. In the past, children with CHD were told they should avoid too much exercise and many are nervous or unable to participate in strenuous sports. However, at CHAMPS, the health of the children is monitored closely and they are encouraged to try new activities and sports to push their existing boundaries.

Every day, the CHAMPS team plans activities that are based on a specific chronic disease management and prevention program for children with CHD. In this way, the children learn what exercises they can do, how to do them, and what their nutrition should look like. From the older children at the camp, the younger ones see what they can be capable of with the right tools and also that they can successfully manage their chronic condition. Additionally, they are able to talk about any health anxiety and emotions that result from their CHD and Dr Erlandson says that this environment helps to alleviate some of this stress.

Dr Erlandson further emphasises how important an improved understanding of their ability to exercise is to the later-life health of these children. Many young people with CHD go on to develop obesity and other disorders because of their lack of knowledge. As such, Dr Erlandson believes dedicated, comprehensive, and affordable chronic disease management programs are essential for reducing preventable morbidity in this population.

Children undertaking team exercise as part of CHAMPS. Credit: Marta Erlandson.

The Multiple Aspects of CHAMPS

The team more recently received additional funding from the Saskatchewan Health Research Foundation to expand their program. This involves extending the program to six months in duration and extending the availability of sessions to parents as well as children. As a result, parents can learn from clinical child psychologists how to communicate with their children about their condition and consequent emotions. As there is little to no infrastructure to support chronic disease management other than standard cardiology visits, this should be a great help for families dealing with CHD.

During CHAMPS camps, children and their families are given the opportunity to be involved in the team’s research. So far, Dr Erlandson has helped to elucidate different aspects of CHD and is continuing to study the disorders. An early study from CHAMPS investigated CHD in relation to arterial stiffness, which is the loss of elasticity and consequent stiffening of artery walls. This creates a high risk of hypertension (high blood pressure) and other serious problems like strokes and children with CHD appear to have a higher risk of arterial stiffness than their healthy counterparts. They studied groups of children with CHD who had low physical activity with those that had high physical activity. Interestingly, they found that those with low activity had clearly increased arterial stiffness compared to those with high activity. Consequently, they concluded that regular physical activity is a beneficial method of minimising arterial stiffness and enhancing the future health of children with CHD.

Another study by the CHAMPS research group examined the health anxiety that children with CHD experience in comparison with children and adolescents that were developing more typically. As predicted, they demonstrated that young people with CHD have significantly higher anxiety surrounding their health. Dr Erlandson says this shows that they have a clinical level of risk for anxiety and therefore, require thorough interventions to help them deal with their condition properly.

Striving for better CHD management

The American Heart Association recommends that children living with CHD should have the same level of physical activity as their healthy peers, as it is both safe and beneficial. However, these children clearly have specific needs that are not currently met by existing programs. Dr Erlandson’s team discovered this through their parents, who also cite financial constraints as an issue.

As a result, Dr Erlandson and the CHAMPS research team are striving to, ‘create a sustainable comprehensive chronic disease management program for children with CHD’ that will improve the current and future lives of the many children living with CHD both in Canada and throughout the world.







Dr Marta Erlandson
College of Kinesiology
University of Saskatchewan

Dr Marta Erlandson achieved her BSc, MSc, and PhD from the College of Kinesiology at the University of Saskatchewan. She also completed a Postdoctoral Research Fellowship at the University Health Network/University of Toronto as part of the College of Medicine’s Osteoporosis and Women’s Health Program. Dr Erlandson now serves as an Assistant Professor in the College of Kinesiology at the University of Saskatchewan. This is also where she also carries out her research into congenital heart disease (CHD). Through her work, Dr Erlandson aims to better understand the physical and psychological needs of children with CHD and develop interventions to help them.


E: marta.erlandson@usask.ca

W: https://kinesiology.usask.ca/people/marta-erlandson.php

Twitter: @ErlandsonMarta


Dr Corey Tomczak, College of Kinesiology, University of Saskatchewan

Dr Kristi Wright, Department of Psychology, University of Regina

Dr Charissa Pockett, Pediatric Cardiology, College of Medicine, University of Saskatchewan


Saskatchewan Health Research Foundation

Canadian Institutes of Health Research – SCPOR Matching funding

Jim Pattison Children Hospital Foundation

Mending Little Hearts Fund of Saskatchewan


AM Oliver, KD Wright, A Kakadekar, et al., Health anxiety and associated constructs in children and adolescents with congenital heart disease: A CHAMPS cohort study, Journal of Health Psychology, 2020, 25(10–11), 1355–1365.

E Barbour-Tuck, NG Boyes, CR Tomczak, et al., A cardiovascular disease risk factor in children with congenital heart disease: unmasking elevated waist circumference – a CHAMPS Study, BMC Cardiovascular Disorders, 2020, 20(1), 231.

NG Boyes, MK Stickland, S Fusnik, et al., Physical activity modulates arterial stiffness in children with congenital heart disease: A CHAMPS cohort study, Congenital Heart Disease, 2018, 13(4), 578–583.


We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence (CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.




Professor Thomas Feuerstein | A Paradox Explained: Why a Super Selective β1-blocker Works in Acute Heart Failure

Professor Thomas Feuerstein | A Paradox Explained: Why a Super Selective β1-blocker Works in Acute Heart Failure

β1-adrenoceptors are found in the heart where they bind neurotransmitters/hormones such as noradrenaline and adrenaline. The binding of these β1-adrenoceptors agonists activates a response in the heart muscle that helps regulate the heart’s beat and contractile force. Drugs that block the action of these receptors are an established treatment for those suffering from left ventricular dysfunction due to chronic heart failure. However, their use in the acute setting is controversial. Professor Thomas Feuerstein of the University Hospital Freiburg in Germany and Dr Günther Krumpl of the Medical Research Network in Vienna are challenging these sceptical attitudes through mathematical modelling.

Dr Xu Hannah Zhang | p38γ – It’s More than Just a Kinase

Dr Xu Hannah Zhang | p38γ – It’s More than Just a Kinase

Kinases take energy from adenosine triphosphate molecules to fuel other molecules in performing vital biological processes. Dr Xu Hannah Zhang at City of Hope, Los Angeles, has worked with colleagues to better understand the p38 family of kinases, and in particular, how the p38γ isoform plays a role in cancer. Her work has shown – for the first time – that p38γ is much more than just a kinase, and her recent studies point to new avenues in the search for cutaneous T-cell lymphoma therapeutics.

Dr Daisuke Minakata – Sunshine and Organic Molecules in Water

Dr Daisuke Minakata – Sunshine and Organic Molecules in Water

Organic molecules dissolved in rivers, lakes, seas and oceans are essential to plant and animal life. Some of these molecules are also degraded and enter a complex cycle of carbon, nitrogen and sulphur containing compounds. Surprisingly, scientists currently have a limited understanding of the fate of these molecules. Dr Daisuke Minakata and his colleagues from Michigan Technological University are involved in an ambitious programme to overcome this critical knowledge gap.

Professor Christian Laforsch | Professor Andreas Greiner – Microplastics: Solutions for a Persistent Pollutant

Professor Christian Laforsch | Professor Andreas Greiner – Microplastics: Solutions for a Persistent Pollutant

Plastics have revolutionised human existence. Medicine, technology, agriculture and construction all rely on highly durable plastic materials. However, the enduring legacy of plastics extends far beyond our cities and towns. Everywhere we look, from the deepest parts of the oceans to alpine glaciers, we find tiny fragments called microplastics. Recently, the collaborative research centre, ‘CRC 1357 Microplastic’, at the University of Bayreuth was granted a second funding phase by the German Science Foundation, to continue their intensive research into microplastics. The CRC 1357 team studies the formation and behaviour of microplastics in the environment and their long-term effects on soils, plants, organisms, and ecosystem processes. Through their research, the University of Bayreuth will be able to contribute to ground-breaking recommendations for policy-makers, industry and society.